A Case Study Examining the Benefits and Challenges of Integrating VHP® Biodecontamination into a High-Volume Compounding Facility
Nephron Pharmaceutical Compounding Facility Integrates STERIS VHP Biodecontamination System
Background
Nephron is a rapidly growing manufacturer of generic respiratory medications and a contract manufacturer of blow-fill-seal products. Also, as a 503B compounder, Nephron has made significant investments in the production of high-volume pharmaceutical preparations for interstate distribution…